Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease.
Gottlieb
G L
GL
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia.
McAllister
T W
TW
Gur
R C
RC
D000368:Aged; D000544:Alzheimer Disease / Q000150:complications*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D012920:Social Behavior Disorders / Q000188:drug therapy* / Q000209:etiology
D003692:Delayed-Action Preparations; C011825:fluphenazine depot; D005476:Fluphenazine